| Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial JS De Bono, S Oudard, M Ozguroglu, S Hansen, JP Machiels, I Kocak, ... The Lancet 376 (9747), 1147-1154, 2010 | 4000 | 2010 |
| Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a … ED Kwon, CG Drake, HI Scher, K Fizazi, A Bossi, AJM Van den Eertwegh, ... The lancet oncology 15 (7), 700-712, 2014 | 1579 | 2014 |
| Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts Helicobacter and Cancer Collaborative Group Gut 49 (3), 347-353, 2001 | 1220 | 2001 |
| Cabazitaxel versus docetaxel as first-line therapy for patients with metastatic castration-resistant prostate cancer: a randomized phase III trial—FIRSTANA S Oudard, K Fizazi, L Sengeløv, G Daugaard, F Saad, S Hansen, ... Journal of Clinical Oncology 35 (28), 3189-3197, 2017 | 382 | 2017 |
| Epidemiology of glioma: Clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry BK Rasmussen, S Hansen, RJ Laursen, M Kosteljanetz, H Schultz, ... Journal of Neuro-oncology 135, 571-579, 2017 | 280 | 2017 |
| Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial B Hasselbalch, U Lassen, S Hansen, M Holmberg, M Sørensen, ... Neuro-oncology 12 (5), 508-516, 2010 | 274 | 2010 |
| The heritability of prostate cancer in the Nordic Twin Study of Cancer JB Hjelmborg, T Scheike, K Holst, A Skytthe, KL Penney, RE Graff, ... Cancer Epidemiology, Biomarkers & Prevention 23 (11), 2303-2310, 2014 | 252 | 2014 |
| Tumour‐associated microglia/macrophages predict poor prognosis in high‐grade gliomas and correlate with an aggressive tumour subtype MD Sørensen, RH Dahlrot, HB Boldt, S Hansen, BW Kristensen Neuropathology and applied neurobiology 44 (2), 185-206, 2018 | 218 | 2018 |
| Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial A Bahl, S Oudard, B Tombal, M Özgüroĝlu, S Hansen, I Kocak, G Gravis, ... Annals of Oncology 24 (9), 2402-2408, 2013 | 206 | 2013 |
| The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients S Hansen, DA Grabau, FB Sørensen, M Bak, W Vach, C Rose Clinical cancer research 6 (1), 139-146, 2000 | 201 | 2000 |
| Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 186 | 2018 |
| Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. S Hansen, DA Grabau, C Rose, M Bak, FB Sørensen Laboratory investigation; a journal of technical methods and pathology 78 …, 1998 | 165 | 1998 |
| Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy C Hagen, HD Schroeder, S Hansen, C Hagen, M Andersen European Journal of Endocrinology 161 (4), 631-637, 2009 | 137 | 2009 |
| Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a … JS De Bono, S Oudard, M Ozguroglu, S Hansen, JH Machiels, L Shen, ... Journal of Clinical Oncology 28 (15_suppl), 4508-4508, 2010 | 133 | 2010 |
| Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer A Knoop, PA Andreasen, JA Andersen, S Hansen, AV Laenkholm, ... British Journal of Cancer 77 (6), 932-940, 1998 | 133 | 1998 |
| Final analysis of the ipilimumab versus placebo following radiotherapy phase III trial in postdocetaxel metastatic castration-resistant prostate cancer identifies an excess of … K Fizazi, CG Drake, TM Beer, ED Kwon, HI Scher, WR Gerritsen, A Bossi, ... European urology 78 (6), 822-830, 2020 | 132 | 2020 |
| Isolated partial rupture of the anterior cruciate ligament Long‐term follow‐up of 56 cases: Long‐term follow‐up of 56 cases K Bak, M Scavenius, S Hansen, K Nørring, KH Jensen, U Jørgensen Knee Surgery, Sports Traumatology, Arthroscopy 5 (2), 66-71, 1997 | 116 | 1997 |
| MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas SK Hermansen, RH Dahlrot, BS Nielsen, S Hansen, BW Kristensen Journal of neuro-oncology 111, 71-81, 2013 | 115 | 2013 |
| What is the clinical value of cancer stem cell markers in gliomas? RH Dahlrot, SK Hermansen, S Hansen, BW Kristensen International journal of clinical and experimental pathology 6 (3), 334, 2013 | 111 | 2013 |
| High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor JD Lathia, M Li, M Sinyuk, AG Alvarado, WA Flavahan, K Stoltz, ... Cell reports 6 (1), 117-129, 2014 | 89 | 2014 |
